08.08.13
Marken has expanded its kit-building operations into Singapore. The facility is fully operational and began shipping for its first client earlier this year. The Singapore site is part of Marken’s ongoing global expansion efforts. In addition to Hamburg and Singapore, Marken is also evaluating an additional kit-building facility in either Miami or Brazil.
The Singapore unit is managed by trained staff and is supported by GMP operators and QA personnel. The depot/kit facility is adjacent to Marken's Singapore distribution hub, located near the Chiangi airport, allowing the company to receive drug product and kit materials, assemble and store kits, as well as store drug product and distribute all clinical materials to investigator sites throughout Asia.
Wes Wheeler, Marken's chief executive officer, said, "We are pleased to be able to offer this expanded service to our clients in the APAC region. Our ability to assemble kits in Singapore gives us a solid platform in Asia and again enhances our portfolio of services to clients in the region. We look forward to serving more global clients with our other facilities as we continue to grow, both in the Asia region and around the world."
The Singapore unit is managed by trained staff and is supported by GMP operators and QA personnel. The depot/kit facility is adjacent to Marken's Singapore distribution hub, located near the Chiangi airport, allowing the company to receive drug product and kit materials, assemble and store kits, as well as store drug product and distribute all clinical materials to investigator sites throughout Asia.
Wes Wheeler, Marken's chief executive officer, said, "We are pleased to be able to offer this expanded service to our clients in the APAC region. Our ability to assemble kits in Singapore gives us a solid platform in Asia and again enhances our portfolio of services to clients in the region. We look forward to serving more global clients with our other facilities as we continue to grow, both in the Asia region and around the world."
